We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Bosch Healthcare Presents Vivalytic Point-of-Care PCR System

By LabMedica International staff writers
Posted on 13 Nov 2023

Bosch Healthcare Solutions (Waiblingen, Germany) is present at this year’s MEDICA to showcase new tests and its universal platform for molecular diagnostics at the point of care. More...

The MEDICA is an annual international trade fair for the medical industry. At the trade fair, exhibitors from all over the world present their latest products, services, and technologies in the fields of medicine, health care, and nursing. MEDICA is an important platform for the exchange of knowledge and experience between professionals in the industry, including doctors, nurses, medical technicians, and healthcare managers. In addition to the exhibition, various forums and conferences are held each year, where experts from different areas of the medical industry give presentations and lead discussions. These forums provide a great opportunity for professionals to learn about the latest trends and developments in their respective fields and to exchange ideas with other experts.

This year, for the first time and exclusively, Bosch Healthcare Solutions is organizing a panel discussion with Vivalytic, and to discuss the topic of laboratory diagnostics at the point of care with experts from various industries. Particular importance will be given to point-of-care PCR systems, such as Vivalytic, which provide rapid test results at the point of sample collection and are easy and intuitive to operate. This exclusive event will provide new insights into the "Third Pillar" of diagnostics. The panelists are proven experts in their field and will be sharing some experiential insights on the topic. Visitors can also attend the round table discussion to learn more about the innovative Vivalytic system and the challenges of the diagnostics sector at the point of care.

Related Links:
Bosch Healthcare Solutions


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Staining Management Software
DakoLink
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.